<scp><i>GBA</i></scp> and <scp><i>APOE</i></scp> Impact Cognitive Decline in Parkinson's Disease: A 10‐Year Population‐Based Study

Abstract

GBA and APOE genotyping could improve the prediction of cognitive decline in PD, which is important to inform the clinical trial selection and potentially to enable personalized treatment © 2022 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.